Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
FDA Grants Priority Review To Roche's Actemra For Hospitalized COVID-19 Adults
Tickers RHHBF RHHBY RHHVF
Tags COVID/19 Coronavirus RHHVF RHHBY
From Benzinga
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
Tickers ABBV AKBA ALNY AMRX
Tags AMRX ABBV TGTX
From Benzinga
Roche's Tiragolumab Immunotherapy Flunks In Late-Stage Lung Cancer Trial
Tickers RHHBF RHHBY RHHVF
Tags RHHBF RHHVF RHHBY
From Benzinga
The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict
Tickers ADGI ADMP AFMD AMLX
Tags Top Stories AMLX JNJ
From Benzinga
Drug makers, Scientists Working For Long COVID Treatments: Reuters
Tickers AXLA GSK HGEN MRNA
Tags PFE Penny Stocks General
From Benzinga
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
Tickers ANTX ATHA BMY CODX
Tags FDA MRK ANTX
From Benzinga
Why Are ImmunoGen Shares Trading Lower Today
Tickers IMGN RHHBY
Tags Downgrades Ovarian Cancer Health Care
From Benzinga
Roche's Evrysdi Shows Long-Term Efficacy, Safety In Broader Spinal Muscular Atrophy Population
Tickers PTCT RHHBF RHHBY RHHVF
Tags Market News News Health Care
From Benzinga
2 Top Stocks to Buy in March and Hold Forever
Tickers NVS RHHBY VIVO
Tags RHHBY VIVO NVS
From Motley Fool
The OTCQX's Top 10 Experience A Shuffle In February
Tickers ADDYY ETHE GBOOY GBTC
Tags Markets SFOR OTC Markets Group
From Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
Tickers ALT ANAB ANIP ATHX
Tags BBI RHHBY ALT
From Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
Tickers BAYRY BAYZF EXEL IPSEY
Tags General RHHBF BAYRY
From Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
Tickers BIIB NVS RHHBY
Tags Market News BIIB Benzinga
From Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
Tickers ACIU ADAP ALDX ALEC
Tags SPPI ATNX CBAY
From Benzinga
OTC Markets 2021 Annual Data Review Highlights A Record 60% $ Volume Increase
Tickers BVNNF GBTC OTCM RHHBY
Tags News otc markets Penny Stocks
From Benzinga
Up 1,000% in 5 Years? These Healthcare Stocks Could Pull It Off.
Tickers AZN HRTX JNJ LEGN
Tags SGEN JNJ PIRS
From Motley Fool
Viatris Just Snagged a Major FDA Approval
Tickers ABBV NVS REGN RHHBY
Tags REGN RHHBY ABBV
From Motley Fool
2 Biotech Stocks That Could Make You Richer
Tickers BMY EXEL ICPT RHHBY
Tags XBI Recent Press Releases Market News
From Motley Fool
Roche And AstraZeneca Settle Ultomiris Patent Lawsuit
Tickers AZN AZNCF RHHBY TAK
Tags AZNCF TKPHF News
From Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
Tickers ANY NVS REGN RHHBF
Tags Market News ANY Benzinga
From Benzinga
3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch
Tickers ARVN BIIB CCCC GOOG
Tags VRTX Market News ARVN
From Motley Fool
These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators
Tickers BNPQY CYDY EEENF ETHE
Tags EEENF SRUUF FMCC
From Benzinga
Why Are Seagen Shares Sinking Today?
Tickers GSK MRK RHHBY SGEN
Tags RHHBY Market News MRK
From Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Tickers ABBV ACLX ALNY AMGN
Tags CLSD ABBV Earnings
From Benzinga
Cathie Wood's Ark Invest Sheds Stake In This Large-Cap Pharma Ahead Of Earnings
Tickers ARKG BNTX MRK PFE
Tags ARKG REGN PFE
From Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
Tickers ABMD ARWR BIIB BMY
Tags NVO CSII DGX
From Benzinga
Roche Expects Slower FY22 Sales Growth On Lower Demand For COVID-19 Tests
Tickers NVS RHHBF RHHBY RHHVF
Tags RHHBY RHHVF Benzinga
From Benzinga
Novartis Expects FY22 Sales, Profit Growth; Sandoz Review Continues
Tickers NVS RHHBF RHHBY RHHVF
Tags Market News Health Care Biotech
From Benzinga
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab
Tickers BIIB RHHBF RHHBY RHHVF
Tags Biotech Benzinga Contracts
From Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
Tickers ABBV ABMD AMLX ARWR
Tags ATHX BIIB EW
From Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.